Clinical Cancer Drugs

Editor-in-Chief:

Giulio Francia
The University of Texas
El Paso, TX
USA

Back

Submit Manuscript
Submit Proposal

Aims & Scope

Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists.